Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 27Non-metastatic Castration-resistant Prostate Cancer 2Neoplasm Metastasis 2Urogenital Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Prostate Cancer Metastatic 1Non-metastatic Prostate Cancer 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms by Site 1Neoplasms 1Metastatic Castration-Resistant Prostate Cancer 1Low Risk Prostate Cancer 1Genital Neoplasms, Male 1Genital Diseases, Male 1Castration Levels of Testosterone 1Advanced Prostate Carcinoma 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × apalutamide × Clear all
NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Pfizer

Completed
1,083 enrolled 29 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03098836 2025-09-12

PANTHER

Duke University

Phase 2 Completed
93 enrolled 17 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡